The findings of this study support the feasibility of using the nasal methylome for future clinical applications, such as predicting the development of asthma among wheezing infants.
Perioperative gabapentin given 300 mg twice daily did not result in reduced narcotic use, but results were compatible with clinically meaningful reductions in pain scores.
Epiglottitis is still a significant pathology seen in EDs, is stable over the study period, and carries a mortality risk.
HTA and the Systematic Human Error Reduction and Prediction Approach (SHERPA) are valuable tools to highlight potential errors in functional endoscopic sinus surgery (FESS).
Patient Reflux Symptom Index (RSI) and Voice Handicap Index (VHI-10) scores improved following voice therapy.
Olfaction can be improved by sinus surgery in about every second chronic rhinosinusitis (CRS) patient.
Voice therapy alone did not result in significant short-term changes for patients with vocal fold polyps (VFPs).
Nimodipine significantly increased the odds of vocal fold motion and facial recovery after injury.
A look at how effective systemic tranexamic acid is compared to a control in blood loss, operative time, and surgical field and incidence of postoperative emesis and thromboembolism in endoscopic sinus surgery (ESS).
Upper airway stimulation (UAS) is successful in treating obstructive sleep apnea (OSA) showing improved outcomes, length of stay, and readmission compared to transoral robotic surgery (TORS).